Exosomes as a Multicomponent Biomarker Platform in Cancer

被引:217
作者
LeBleu, Valerie S. [1 ]
Kalluri, Raghu [2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA
来源
TRENDS IN CANCER | 2020年 / 6卷 / 09期
关键词
EXTRACELLULAR VESICLES; DNA; SECRETION; CELLS; KRAS;
D O I
10.1016/j.trecan.2020.03.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is a complex disease that is associated with genetic aberrations and subsequent cellular and noncellular host responses. Tumors harbor diverse cell types that engage in a dynamic interplay to sustain cancer-specific signaling networks. A component of such cellular communication is the production and exchange of various types of extracellular vesicle (EV). Exosomes are small EVs with growing recognition for their role in cancer progression and resistance to therapy. The unique biogenesis of exosomes, their ubiquitous production by all cell types, and their biological features in liquid biopsies have generated excitement for their potential as cancer biomarkers. Here, we discuss the challenges and utility of exosomes as multiparameter biomarker platforms for the detection of cancer. Exosomes reflect heterogeneous biological changes associated with growing tumors, potentially offering a more comprehensive assessment of cancer diagnosis, prognosis, and progression.
引用
收藏
页码:767 / 774
页数:8
相关论文
共 53 条
[1]   Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
CANCER DISCOVERY, 2016, 6 (05) :479-491
[2]   High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients [J].
Allenson, K. ;
Castillo, J. ;
San Lucas, F. A. ;
Scelo, G. ;
Kim, D. U. ;
Bernard, V. ;
Davis, G. ;
Kumar, T. ;
Katz, M. ;
Overman, M. J. ;
Foretova, L. ;
Fabianova, E. ;
Holcatova, I. ;
Janout, V. ;
Meric-Bernstam, F. ;
Gascoyne, P. ;
Wistuba, I. ;
Varadhachary, G. ;
Brennan, P. ;
Hanash, S. ;
Li, D. ;
Maitra, A. ;
Alvarez, H. .
ANNALS OF ONCOLOGY, 2017, 28 (04) :741-747
[3]   Designer exosomes as next-generation cancer immunotherapy [J].
Bell, Brandon M. ;
Kirk, Isabel D. ;
Hiltbrunner, Stefanie ;
Gabrielsson, Susanne ;
Bultema, Jarred J. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (01) :163-169
[4]   Exosomes in bodily fluids are a highly stable resource of disease biomarkers [J].
Boukouris, Stephanie ;
Mathivanan, Suresh .
PROTEOMICS CLINICAL APPLICATIONS, 2015, 9 (3-4) :358-367
[5]  
Castellanos-Rizaldos Elena, 2019, Oncotarget, V10, P2911, DOI 10.18632/oncotarget.26885
[6]   The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome [J].
Caswell, Deborah R. ;
Swanton, Charles .
BMC MEDICINE, 2017, 15
[7]   Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles [J].
Colombo, Marina ;
Raposo, Graca ;
Thery, Clotilde .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30, 2014, 30 :255-289
[8]   Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver [J].
Costa-Silva, Bruno ;
Aiello, Nicole M. ;
Ocean, Allyson J. ;
Singh, Swarnima ;
Zhang, Haiying ;
Thakur, Basant Kumar ;
Becker, Annette ;
Hoshino, Ayuko ;
Mark, Milica Tesic ;
Molina, Henrik ;
Xiang, Jenny ;
Zhang, Tuo ;
Theilen, Till-Martin ;
Garcia-Santos, Guillermo ;
Williams, Caitlin ;
Ararso, Yonathan ;
Huang, Yujie ;
Rodrigues, Goncalo ;
Shen, Tang-Long ;
Labori, Knut Jorgen ;
Lothe, Inger Marie Bowitz ;
Kure, Elm H. ;
Hernandez, Jonathan ;
Doussot, Alexandre ;
Ebbesen, Saya H. ;
Grandgenett, Paul M. ;
Hollingsworth, Michael A. ;
Jain, Maneesh ;
Mallya, Kavita ;
Batra, Surinder K. ;
Jarnagin, William R. ;
Schwartz, Robert E. ;
Matei, Irina ;
Peinado, Hector ;
Stanger, Ben Z. ;
Bromberg, Jacqueline ;
Lyden, David .
NATURE CELL BIOLOGY, 2015, 17 (06) :816-+
[9]   Translating insights into tumor evolution to clinical practice: promises and challenges [J].
Fittall, Matthew W. ;
Van Loo, Peter .
GENOME MEDICINE, 2019, 11 (1)
[10]   The Tumor Microenvironment Innately Modulates Cancer Progression [J].
Hinshaw, Dominique C. ;
Shevde, Lalita A. .
CANCER RESEARCH, 2019, 79 (18) :4557-4566